URINE

Submit specimen in a sterile container within one hour of collection. 

Indicate in the CPOE request if urine collected is "voided" or "catheterised". Clinical information is essential as instrumentation and the presence of urinary tract stones may result in cytologic changes that mimic malignancy. 

If detection of eosinophils is required, indicate clearly in the CPOE request. 

If detection of polyomavirus/BK virus is required, indicate clearly in the CPOE request. Immunocytochemistry test (SV40) may be required for confirmation.

Urine Cytology is used as a non-invasive screening tool for:

1.    Diagnosing high-grade urothelial carcinoma

2.    Monitoring for recurrence or progression in patients with history of urothelial carcinoma

3.    Evaluation of hematuria

4.    Screening of high-risk individuals (e.g. exposure to certain chemical or radiation therapy)

5.    Assessing inflammation (UTIs)

6.    Detecting specific viral infections, such as polyomavirus in kidney transplant recipients

5 working days (excluding additional immunocytochemistry stain)

​Daily